N/A
Completed N=411
Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)
Peripheral Pulmonary Lesions
Source: ClinicalTrials.gov NCT05705544 ↗
Enrolled (actual)
411
Serious AEs
2.9%
Results posted
Apr 2025
Primary outcomePrimary: Diagnostic Yield — 157; 158 Participants
Summary
This is an investigator-initiated, cluster randomized controlled trial. The primary objective is to compare the diagnostic yield of the Ion™ Endoluminal System (SSCB) to the ILLUMISITE™ Platform (EMN bronchoscopy) in patients undergoing bronchoscopy for peripheral pulmonary lesion (PPL) evaluation.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Diagnostic Yield |
157; 158 | — |
| SECONDARY Duration of Procedure |
32.0; 37.0 | — |
Eligibility Criteria
Inclusion Criteria
18 years of age or older at time of bronchoscopy.
Scheduled for navigational bronchoscopy for the evaluation of a peripheral pulmonary lesion.
Exclusion Criteria
Enrolled in a different study requiring use of one of these specific platforms (i.e., ILLUMISITE™ Platform (EMN) or Ion™ Endoluminal System (SSCB)).
Subject declines to participate.
Data sourced from ClinicalTrials.gov (NCT05705544). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.